Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
N-Cadherin Dynamically Regulates Schwannoma Migration and Represents a Novel Therapeutic Target in NF2-Related Schwannomatosis.
Journal: Research square
Published: February 27, 2026
Proteomic Analysis Identifies Novel Plasma Biomarkers in Patients With Vestibular Schwannoma.
Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Published: November 17, 2025
Matrix Metalloproteinase‑9 (MMP-9) Activatable Gold Nanoparticles for In Situ Zymography and Diagnostics of Neurofibromatosis Type 2 (NF2) Tumors.
Journal: ACS applied nano materials
Published: October 15, 2025
Effect of Alirocumab Monotherapy vs Ezetimibe Plus Statin Therapy on LDL-C Lowering in Veterans With History of ASCVD.
Journal: Federal practitioner : for the health care professionals of the VA, DoD, and PHS
Published: January 22, 2025
Plasma Matrix Metalloproteinase-9 Predicts Intraoperative Experience and Extent of Resection in Vestibular Schwannoma Surgery.
Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Published: September 19, 2024
Quantitative Assessment of Collagen Architecture to Determine Role of Tumor Stroma During Vestibular Schwannoma Progression.
Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Published: August 26, 2024
Matrix metalloproteinase 9: An emerging biomarker for classification of adherent vestibular schwannoma.
Journal: Neuro-oncology advances
Published: June 18, 2024
Showing 1-7 of 7
Last Updated: 09/26/2026